{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T03:10:11Z","timestamp":1785726611888,"version":"3.56.0"},"reference-count":61,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T00:00:00Z","timestamp":1530230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Geriatrics"],"abstract":"<jats:p>Background: Giant cell arteritis\/temporal arteritis (GCA) is an inflammatory condition that affects large to medium vessels such as the aorta and its primary branches. Patients classically present with fatigue, fever, headache, jaw claudication and in severe cases, may suffer either transient (amaurosis fugax) or permanent visual loss. The reference standard for diagnosis is the temporal artery biopsy (TAB) and the mainstay of treatment is with immunosuppression. Our patient JG, presented with a range of non-specific symptoms that mimicked generalised sepsis, but was ultimately diagnosed with GCA through effective, methodical multi-disciplinary team (MDT) work. Clinical case: JG, an 81 year old gentleman, presented acutely with a 3\u20134 weeks history of fatigue, lethargy, pyrexia and a marked inflammatory response suggestive of a sepsis but without a clear primary source or clinical features of vasculitis. His inflammatory markers were markedly raised although his erythrocyte sedimentation rate (ESR) was not elevated. He was initially treated for sepsis of unknown origin however, body imaging after admission suggested a possible infection around a previous aortic graft site. This was refuted in subsequent 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET\/CT) scanning. Microbiological, parasitic, as well as autoimmune assays were unremarkable. He underwent a TAB which was diagnostic for GCA and as a result, was started on oral corticosteroids with immediate symptom relief. He was discharged and followed up on an outpatient basis. Conclusions: This case highlights how a vasculitis can present with a range of non-specific symptoms that may resemble a fever of unknown origin (FUO)\/sepsis that can lead to a delay in making the correct diagnosis. It also highlights the importance of considering a diagnosis of vasculitis in patients who present with a FUO where there is no clear focus of infection. Delays in diagnosis and management of these conditions can potentially lead to significant irreversible morbidity.<\/jats:p>","DOI":"10.3390\/geriatrics3030036","type":"journal-article","created":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T10:51:50Z","timestamp":1530269510000},"page":"36","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Stab in the Dark: A Case Report of an Atypical Presentation of Giant Cell Arteritis (GCA)"],"prefix":"10.3390","volume":"3","author":[{"given":"Beth","family":"McCausland","sequence":"first","affiliation":[{"name":"Medicine for Older People, University Hospital Southampton, Southampton SO16 6YD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Desai","sequence":"additional","affiliation":[{"name":"Medicine for Older People, University Hospital Southampton, Southampton SO16 6YD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Havard","sequence":"additional","affiliation":[{"name":"Medicine for Older People, University Hospital Southampton, Southampton SO16 6YD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Kaur","sequence":"additional","affiliation":[{"name":"Medicine for Older People, University Hospital Southampton, Southampton SO16 6YD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asalet","family":"Yener","sequence":"additional","affiliation":[{"name":"Medicine for Older People, University Hospital Southampton, Southampton SO16 6YD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Bradley","sequence":"additional","affiliation":[{"name":"Medicine for Older People, University Hospital Southampton, Southampton SO16 6YD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0081-1802","authenticated-orcid":false,"given":"Harnish P.","family":"Patel","sequence":"additional","affiliation":[{"name":"Medicine for Older People, University Hospital Southampton, Southampton SO16 6YD, UK"},{"name":"Academic Geriatric Medicine, University of Southampton, University Hospital, Southampton SO16 6YD, UK"},{"name":"NIHR Biomedical Research Centre Southampton, University of Southampton, Southampton SO16 6YD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,6,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.7453\/gahmj.2013.008","article-title":"The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development","volume":"2","author":"Gagnier","year":"2013","journal-title":"Glob. Adv. Health Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/ard.2005.046912","article-title":"Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990\u20132001","volume":"65","author":"Smeeth","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"Itc65","DOI":"10.7326\/AITC201611010","article-title":"Giant Cell Arteritis","volume":"165","author":"Hoffman","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"ref_5","first-page":"S98","article-title":"Systemic vasculitis: An annual critical digest of the most recent literature","volume":"32","author":"Cioffi","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/1529-0131(199811)41:11<1960::AID-ART10>3.0.CO;2-X","article-title":"Giant cell arteritis and cardiovascular risk factors: A multicenter, prospective case-control study","volume":"41","author":"Duhaut","year":"1998","journal-title":"Arthritis Rheum."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/ard.2005.039404","article-title":"Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis","volume":"65","author":"Larsson","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e3213","DOI":"10.1097\/MD.0000000000003213","article-title":"A Retrospective Study of Chinese Patients With Giant Cell Arteritis (GCA): Clinical Features and Factors Associated with Severe Ischemic Manifestations","volume":"95","author":"Sun","year":"2016","journal-title":"Medicine"},{"key":"ref_9","first-page":"112","article-title":"Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection","volume":"23","author":"Elling","year":"1996","journal-title":"J. Rheumatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamaneurol.2015.2101","article-title":"Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis","volume":"72","author":"Nagel","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1212\/WNL.0000000000001409","article-title":"Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis","volume":"84","author":"Gilden","year":"2015","journal-title":"Neurology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1002\/art.38625","article-title":"Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica","volume":"66","author":"Abdulahad","year":"2014","journal-title":"Arthritis Rheum."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.7861\/clinmedicine.10-4-381","article-title":"Concise guidance: Diagnosis and management of giant cell arteritis","volume":"10","author":"Dasgupta","year":"2010","journal-title":"Clin. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/rheumatology\/kex333","article-title":"Discrepancies between vascular and systemic inflammation in large vessel vasculitis: An important problem revisited","volume":"57","author":"Keser","year":"2018","journal-title":"Rheumatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20900","article-title":"The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): A diagnostic accuracy and cost-effectiveness study","volume":"20","author":"Luqmani","year":"2016","journal-title":"Health Technol. Assess."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.md.0000119761.27564.c9","article-title":"Risk factors for cranial ischemic complications in giant cell arteritis","volume":"83","author":"Nesher","year":"2004","journal-title":"Medicine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3399\/bjgp12X649313","article-title":"Diagnosis and management of giant cell arteritis","volume":"62","author":"Barraclough","year":"2012","journal-title":"Br. J. Gen. Pract."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.semarthrit.2011.10.005","article-title":"Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis","volume":"41","author":"Kermani","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_19","first-page":"746","article-title":"Discordance between erythrocyte sedimentation rate and C-reactive protein measurements: Clinical significance","volume":"25","author":"Costenbader","year":"2007","journal-title":"Clin. Exp. Rheum."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/art.20523","article-title":"Fever in biopsy-proven giant cell arteritis: Clinical implications in a defined population","volume":"51","author":"Llorca","year":"2004","journal-title":"Arthritis Rheum."},{"key":"ref_21","first-page":"1272","article-title":"Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course","volume":"30","author":"Liozon","year":"2003","journal-title":"J. Rheumatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/art.1780241113","article-title":"Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin","volume":"24","author":"Calamia","year":"1981","journal-title":"Arthritis Rheum."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2165\/11592500-000000000-00000","article-title":"Polymyalgia Rheumatica and Giant Cell Arteritis in Older Patients","volume":"28","author":"Schmidt","year":"2011","journal-title":"Drugs Aging"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11926-014-0480-1","article-title":"Giant cell arteritis and polymyalgia rheumatica: An update","volume":"17","author":"Pina","year":"2015","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jcjo.2016.05.021","article-title":"Clinical predictors of positive temporal artery biopsy","volume":"51","author":"Toren","year":"2016","journal-title":"Can. J. Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e3818","DOI":"10.1097\/MD.0000000000003818","article-title":"Giant-cell arteritis without cranial manifestations","volume":"95","author":"Liozon","year":"2016","journal-title":"Medicine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/00000478-199206000-00014","article-title":"False-negative temporal artery biopsy","volume":"16","author":"Gallagher","year":"1992","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/ard.2005.042770","article-title":"Temporal artery biopsy for diagnosing giant cell arteritis: The longer, the better?","volume":"65","author":"Mahr","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/ans.13822","article-title":"Value of temporal artery biopsy length in diagnosing giant cell arteritis","volume":"88","author":"Oh","year":"2018","journal-title":"ANZ J. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/bjo.86.5.530","article-title":"Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis","volume":"86","author":"Kine","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Arida, A., Kyprianou, M., Kanakis, M., and Sfikakis, P.P. (2010). The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: A second meta-analysis. BMC Musculoskelet. Disord., 11.","DOI":"10.1186\/1471-2474-11-44"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/bjs.7252","article-title":"Role of ultrasonography in the diagnosis of temporal arteritis","volume":"97","author":"Ball","year":"2010","journal-title":"Br. J. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7326\/0003-4819-142-5-200503010-00011","article-title":"Meta-analysis: Test performance of ultrasonography for giant-cell arteritis","volume":"142","author":"Karassa","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/rheumatology\/kex173","article-title":"The use of ultrasound to assess giant cell arteritis: Review of the current evidence and practical guide for the rheumatologist","volume":"57","author":"Monti","year":"2018","journal-title":"Rheumatology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1002\/art.23699","article-title":"Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis","volume":"58","author":"Bley","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1148\/radiol.14140056","article-title":"Giant cell arteritis: Diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial","volume":"273","author":"Klink","year":"2014","journal-title":"Radiology"},{"key":"ref_38","first-page":"123","article-title":"Do clinical and laboratory variables have any impact on the diagnostic performance of 18F-FDG PET\/CT in patients with fever of unknown origin?","volume":"32","author":"Pradas","year":"2017","journal-title":"Ann. Nucl. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1749-6632.2011.06021.x","article-title":"PET in vasculitis","volume":"1228","author":"Blockmans","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1097\/MD.0000000000000622","article-title":"Management of large-vessel vasculitis with FDG-PET: A systematic literature review and meta-analysis","volume":"94","author":"Soussan","year":"2015","journal-title":"Medicine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00259-018-4021-4","article-title":"Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy","volume":"45","author":"Nielsen","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice","volume":"77","author":"Dejaco","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e000612","DOI":"10.1136\/rmdopen-2017-000612","article-title":"Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: A systematic literature review and meta-analysis informing the EULAR recommendations","volume":"4","author":"Duftner","year":"2018","journal-title":"RMD Open"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/TCRM.S13088","article-title":"Optimal management of giant cell arteritis and polymyalgia rheumatica","volume":"8","author":"Charlton","year":"2012","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/rheumatology\/keq039a","article-title":"BSR and BHPR guidelines for the management of giant cell arteritis","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.20171","article-title":"Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis","volume":"50","author":"Nesher","year":"2004","journal-title":"Arthritis Rheum."},{"key":"ref_47","unstructured":"NICE (2018, June 24). Giant Cell Arteritis. Available online: www.nice.org.uk\/giant-cell-arteritis#!scenario."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.revmed.2013.02.031","article-title":"Glucocorticoid-induced adverse events in patients with giant cell arteritis or polymyalgia rheumatica","volume":"34","author":"Fardet","year":"2013","journal-title":"La Revue Med. Intern."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/art.22754","article-title":"Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta-analysis","volume":"56","author":"Mahr","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/14397595.2016.1266070","article-title":"Treatment of giant-cell arteritis, a literature review","volume":"27","author":"Watelet","year":"2017","journal-title":"Mod. Rheumatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(16)00560-2","article-title":"Tocilizumab for induction and maintenance of remission in giant cell arteritis: A phase 2, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Villiger","year":"2016","journal-title":"Lancet"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of Tocilizumab in Giant-Cell Arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N. Eng. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/jgf2.35","article-title":"Key diagnostic features of fever of unknown origin: Medical history and physical findings","volume":"18","author":"Takeda","year":"2017","journal-title":"J. Gen. Fam. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00296-012-2415-3","article-title":"Dry cough is a frequent manifestation of giant cell arteritis","volume":"33","author":"Zenone","year":"2013","journal-title":"Rheumatol. Int."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2230.2008.03008.x","article-title":"Hypereosinophilic syndrome with various skin lesions and juvenile temporal arteritis","volume":"34","author":"Ito","year":"2009","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/PAS.0000000000000244","article-title":"Inflamed temporal artery: Histologic findings in 354 biopsies, with clinical correlations","volume":"38","author":"Cavazza","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10067-010-1616-y","article-title":"Delays in recognition and management of giant cell arteritis: Results from a retrospective audit","volume":"30","author":"Ezeonyeji","year":"2011","journal-title":"Clin. Rheumatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1002\/art.11480","article-title":"Mortality of large-artery complication (aortic aneurysm, aortic dissection, and\/or large-artery stenosis) in patients with giant cell arteritis: A population-based study over 50 years","volume":"48","author":"Nuenninghoff","year":"2003","journal-title":"Arthritis Rheum."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/annrheumdis-2014-205665","article-title":"The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: A general population-based study","volume":"75","author":"Bhole","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejim.2017.08.013","article-title":"Repetitive (18)F-FDG-PET\/CT in patients with large-vessel giant-cell arteritis and controlled disease","volume":"46","author":"Aide","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.autrev.2017.09.007","article-title":"Is PET\/CT essential in the diagnosis and follow-up of temporal arteritis?","volume":"16","author":"Salvarani","year":"2017","journal-title":"Autoimmun. Rev."}],"container-title":["Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3417\/3\/3\/36\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:10:42Z","timestamp":1760195442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3417\/3\/3\/36"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,29]]},"references-count":61,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["geriatrics3030036"],"URL":"https:\/\/doi.org\/10.3390\/geriatrics3030036","relation":{},"ISSN":["2308-3417"],"issn-type":[{"value":"2308-3417","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,29]]}}}